Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome
- Status
- SUSPENDED
- Phase
- PHASE2
BGT007 Cell Treatment of Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease
- Status
- TERMINATED
- Phase
- PHASE1
Natural Killer(NK) Cell Therapy for Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.
- Status
- TERMINATED
- Phase
- PHASE2
Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML
- Status
- TERMINATED
- Phase
- PHASE1
CISH Inactivated TILs in the Treatment of NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
CD34+ Transplants for Leukemia and Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2